Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.3964
Delayed Data
As of 10:56am ET
 -0.0161 / -3.90%
Today’s Change
0.17
Today|||52-Week Range
1.05
-37.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues11.0M6.9M3.5M1.1M
 
 
 
 
 
Cost of Goods Sold--0.00162.0K254.0K
 
 
 
Depreciation And Amortization425.0K341.0K314.0K232.0K
 
 
 
 
 
 
Operating ExpensesGross Income--6.6M3.0M568.0K
 
 
 
 
General Expenses14.9M14.9M18.5M17.4M
 
 
 
 
 
Research And Development9.9M9.3M12.5M9.5M
 
 
 
 
 
Total Operating Expenses15.3M15.3M19.0M17.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.3M-8.3M-15.5M-16.9M
 
 
 
 
 
Extraordinary Credit0.001.4M--1.7M
 
 
 
Extraordinary Charge-732.0K0.00-555.0K--
 
 
 
Other Expenses-30.0K-155.0K1.0K22.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.1M-7.0M-16.0M-15.2M
 
 
 
 
 
Income Taxes-2.0K-2.0K-2.0K-2.0K
 
 
 
 
 
Net Income-5.1M-7.0M-16.0M-15.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.8M29.4M38.2M49.6M
 
 
 
 
 
Shares To Calculate EPS Diluted25.8M29.4M38.2M49.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20-$0.24-$0.42-$0.31
 
 
 
 
 
EPS Diluted-$0.20-$0.24-$0.42-$0.31